Volume 10, Number 8—August 2004
Research
Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management
Table 3
Case identification | Plan A (%) | Plan B (%) | Plan C (%) | Total (%) |
---|---|---|---|---|
Pharmacy screening only | 3 (6) | 1 (5) | 9 (7) | 13 (6) |
State health department only (all cases) | 38 (72) | 15 (68) | 80 (61) | 133 (64) |
State health department only (health plan–treated patients) | 16 (52) | 2 (22) | 0a | 18 (19) |
Both methods | 12 (22) | 6 (27) | 43 (32) | 61 (30) |
Total (all cases) | 53 | 22 | 132 | 207 |
Total (health plan–treated patientsb) | 31 | 9 | 52 | 92 |
aExtrapolated from review of a random sample of 28 of the 80 TB cases identified by the state health department and not by pharmacy screening.
bExcludes TB patients receiving anti-TB medication from public health clinics; these medications are not included in the health plan pharmacy databases.
Page created: June 14, 2011
Page updated: June 14, 2011
Page reviewed: June 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.